You are here

Industry News

Advamed Smart Brief

February 21, 2018
Orthotaxy, a French company that develops software-enabled surgery technologies, was acquired by Johnson & Johnson through it -More
February 21, 2018
An addition of $1.5 billion to an existing share repurchasing plan of Baxter was approved by the company's board of directors -More
February 21, 2018
Medtronic's diabetes division saw a 17% increase in sales during the fiscal third quarter ending Jan.  -More
February 21, 2018
The Fraunhofer Centre for Applied Photonics and Mologic are working together to create a rapid, point-of-care test that will  -More
February 21, 2018
Scott Drake, a director at AtriCure, was tapped to serve as chairman of the board at the company beginning in May.  -More
February 21, 2018
A rule requiring medical device clinical trials conducted in foreign countries to flexibly comply with Good Clinical Practice -More
February 21, 2018
Stick-on throat sensors have been developed by scientist John Rogers at Northwestern University in partnership with the Shirl -More
February 21, 2018
The Dario blood glucose monitoring system is now on the Amazon marketplace, giving DarioHealth more purchasing and shipping o -More
February 21, 2018
Corindus Vascular Robotics' CorPath GRX system was granted 510(k) clearance by the FDA for use in peripheral vascular interve -More
February 21, 2018
The FDA granted Siemens Healthineers clearance to market its GOKnee3D MRI software application, which is available for the co -More

Industry News

Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.
PR Newswire
Royal Philips, a global leader in health technology, today announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians' use of Azurion resulted in significant time savings for the hospital, including a 17...
Modern Healthcare
In 1958, Arne Larsson was hospitalized in Sweden with a complete heart block, and his prognosis was bleak. That’s when a team of surgeons, led by Dr. Ake Senning, surgically placed the first implantable pacemaker inside Larsson to increase his heart’s number of beats per minute from 25 to the normal rate of 70. Thanks to technological innovation, the then 43-year-old Larsson lived to be 90 years old. Since then, several new innovations have come to market, including pacemakers operated by...
PR Newswire
MINNETONKA, Minn., Oct. 10, 2017 /PRNewswire/ -- Respicardia, Inc., a private medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) approval of its remedē® System, a transvenous implantable neurostimulation system that stimulates the phrenic nerve, and engages the diaphragm to restore natural breathing during sleep in patients with central sleep apnea (CSA). The regulatory approval was based on findings from the remedē System pivotal trial, which...